Transaction
|
December 14, 2021

Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

VIEW ORIGINAL PRESS RELEASE
Latest News
Transaction
MolecuLight Secures $11.7 Million in Financing to Accelerate Global Expansion
Transaction
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
Transaction
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
Transaction
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
Transaction
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
BACK TO NEWS
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Tungsten Partners LLC d/b/a Tungsten Advisors is not a registered broker-dealer, and Finalis Securities LLC and Tungsten Partners LLC d/b/a Tungsten Advisors are separate, unaffiliated entities.

www.tungstenadv.com is operated by Tungsten Partners LLC, a privately held Delaware Limited Liability Company. Tungsten Partners LLC provides strategic advisory services.

Business Continuity Plan  |  Privacy Policy  |  FINRA Broker Check

CONTACT:
INFO@tungstenadv.com
CONNECT:
LINKED IN
ADDRESS:
767 Third Ave, 29th Floor
New York, NY 10017
CONTACT:
INFO@tungstenadv.com
CONNECT:
LINKED IN
ADDRESS:
767 Third Ave, 29th Floor
New York, NY 10017

Securities are offered through Finalis Securities LLC Member FINRA/SIPC. Tungsten Partners LLC d/b/a Tungsten Advisors and Finalis Securities LLC are separate, unaffiliated entities.

www.tungstenadv.com is operated by Tungsten Partners LLC, a privately held Delaware Limited Liability Company. Tungsten Partners LLC provides strategic advisory services.

Business Continuity Plan  |  Privacy Policy  |  FINRA Broker Check